High rate of BA.1, BA.1.1 and BA.2 infection in triple vaccinated
Ulrika Marking, Sebastian Havervall, Nina Greilert Norin, Wanda Christ, Max Gordon, Henry Ng, Kim Blom, Mia Phillipson, Sara Mangsbo, Anna Smed Sörensen, Peter Nilsson, Sophia Hober, Mikael Åberg, Jonas Klingström, View ORCID ProfileCharlotte Thålin
doi: https://doi.org/10.1101/2022.04.02.22273333
Ulrika Marking
1Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden
Sebastian Havervall
1Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden
Nina Greilert Norin
1Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden
Wanda Christ
2Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden
Max Gordon
1Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden
Henry Ng
3Department of Medical Cell Biology and SciLifeLab, Uppsala University, Uppsala, Sweden
Kim Blom
1Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden
Mia Phillipson
3Department of Medical Cell Biology and SciLifeLab, Uppsala University, Uppsala, Sweden
Sara Mangsbo
4Department of Pharmacy and SciLifeLab, Uppsala University, Uppsala, Sweden
Anna Smed Sörensen
5Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Peter Nilsson
6Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
Sophia Hober
6Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
Mikael Åberg
7Department of Medical Sciences, Clinical Chemistry and SciLifeLab, Uppsala University, Uppsala, Sweden
Jonas Klingström
2Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden
Charlotte Thålin
1Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted April 03, 2022.
High rate of BA.1, BA.1.1 and BA.2 infection in triple vaccinated
Ulrika Marking, Sebastian Havervall, Nina Greilert Norin, Wanda Christ, Max Gordon, Henry Ng, Kim Blom, Mia Phillipson, Sara Mangsbo, Anna Smed Sörensen, Peter Nilsson, Sophia Hober, Mikael Åberg, Jonas Klingström, Charlotte Thålin
medRxiv 2022.04.02.22273333; doi: https://doi.org/10.1101/2022.04.02.22273333
High rate of BA.1, BA.1.1 and BA.2 infection in triple vaccinated
Ulrika Marking, Sebastian Havervall, Nina Greilert Norin, Wanda Christ, Max Gordon, Henry Ng, Kim Blom, Mia Phillipson, Sara Mangsbo, Anna Smed Sörensen, Peter Nilsson, Sophia Hober, Mikael Åberg, Jonas Klingström, Charlotte Thålin
medRxiv 2022.04.02.22273333; doi: https://doi.org/10.1101/2022.04.02.22273333
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (718)
- Anesthesia (211)
- Cardiovascular Medicine (3007)
- Dermatology (256)
- Emergency Medicine (450)
- Epidemiology (12911)
- Forensic Medicine (12)
- Gastroenterology (841)
- Genetic and Genomic Medicine (4707)
- Geriatric Medicine (433)
- Health Economics (742)
- Health Informatics (2992)
- Health Policy (1083)
- Hematology (400)
- HIV/AIDS (946)
- Medical Education (440)
- Medical Ethics (116)
- Nephrology (482)
- Neurology (4497)
- Nursing (239)
- Nutrition (660)
- Oncology (2333)
- Ophthalmology (663)
- Orthopedics (262)
- Otolaryngology (330)
- Pain Medicine (291)
- Palliative Medicine (85)
- Pathology (506)
- Pediatrics (1218)
- Primary Care Research (510)
- Public and Global Health (7082)
- Radiology and Imaging (1571)
- Respiratory Medicine (934)
- Rheumatology (455)
- Sports Medicine (391)
- Surgery (500)
- Toxicology (63)
- Transplantation (215)
- Urology (187)